Article Details

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Recommendation of "Buy" by Analysts

Retrieved on: 2021-03-13 06:35:28

Tags for this article:

Click the tags to see associated articles and topics

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Recommendation of "Buy" by Analysts. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 554,889 shares of the company's stock worth $9,689,000 after acquiring an additional 132,920 shares in the last quarter. AXA ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up